EGFR signaling is frequently disrupted in various human cancers, which can result from gene amplification, increased protein expression, activating mutations, or in-frame deletions within the EGFR gene.17 In numerous instances, genetic changes in EGFR lead to abnormal receptor trafficking, resulting in enhanced signaling activity and promoting tumor growth. The gene discussed is EGFR; the disease is cancer.